Related Experiment Videos
Complement activation after myocardial infarction
Insights
Complement activation was studied in myocardial infarction patients. Elevated C3d levels in postmyocardial infarction syndrome (PMIS) patients suggest immune complex formation and complement-mediated damage, aiding differentiation from pulmonary embolism.
Area of Science:
- Immunology
- Cardiology
- Biochemistry
Background:
- Myocardial infarction (MI) can lead to complications like postmyocardial infarction syndrome (PMIS) and pulmonary embolism (PE).
- Complement system activation is implicated in inflammatory and immune responses.
- Assessing complement component levels may provide insights into disease mechanisms and differentiation.
Purpose of the Study:
- To investigate complement activation patterns in patients post-myocardial infarction.
- To explore the role of complement in postmyocardial infarction syndrome (PMIS).
- To evaluate the utility of complement levels in differentiating PMIS from pulmonary embolism (PE).
Main Methods:
- Studied complement levels (C3, C4, C3d) in 56 MI patients and 25 controls.
- Categorized patients into groups: PMIS, prolonged pyrexia, PE, and uncomplicated MI.
- Analyzed complement levels in relation to clinical conditions and disease activity.
Main Results:
- Elevated C3d levels were observed in most MI patients during the first ten days and during PE, suggesting non-immunologic complement utilization.
- PMIS patients exhibited significantly higher C3d levels and lower C3 concentrations during active disease.
- High C3d levels in PMIS may indicate immune complex deposition and complement-mediated tissue damage.
Conclusions:
- Complement activation, particularly via elevated C3d, is associated with PMIS following myocardial infarction.
- The findings suggest a potential role for heart-reactive antibodies and immune complexes in PMIS pathogenesis.
- Complement C3d levels may serve as a biomarker to differentiate PMIS from PE in MI patients.
Abstract:
Complement activation as reflected by C3, C4, and C3d levels was studied in 56 patients following myocardial infarction, 13 with the postmyocardial infarction syndrome (PMIS); 12 with prolonged postinfarction pyrexia; six with clinical evidence of pulmonary embolism; and 25 control patients without apparent complications. In most patients, C3d levels were elevated during the first ten postinfarction days and at the time of any pulmonary embolism; this probably represented local nonimmunologic complement utilization. The PMIS patients had much higher C3d levels associated with significantly lower concentrations of C3 at the time of disease activity. It is suggested that heart reactive antibodies combine with circulating cardiac antigens to form soluble immune complexes, and in the PMIS, these may become deposited in various sites resulting in complement-mediated tissue damage. The high C3d levels associated with the PMIS may also be of value in differentiating this condition from pulmonary embolism, as both problems may have similar clinical and roentgenographic features.